Page last updated: 2024-11-04

tetracaine and Eye Pain

tetracaine has been researched along with Eye Pain in 16 studies

Tetracaine: A potent local anesthetic of the ester type used for surface and spinal anesthesia.
tetracaine : A benzoate ester in which 4-N-butylbenzoic acid and 2-(dimethylamino)ethanol have combined to form the ester bond; a local ester anaesthetic (ester caine) used for surface and spinal anaesthesia.

Eye Pain: A dull or sharp painful sensation associated with the outer or inner structures of the eyeball, having different causes.

Research Excerpts

ExcerptRelevanceReference
"The objective of this study was to test the hypothesis that topical tetracaine would be safe to use for 24 hours and would not affect corneal healing, that patients would experience more pain relief, and that patients would perceive tetracaine to be more effective than saline eye drops for the treatment of pain caused by corneal abrasions."2.79Topical tetracaine used for 24 hours is safe and rated highly effective by patients for the treatment of pain caused by corneal abrasions: a double-blind, randomized clinical trial. ( Densie, IK; Herbison, P; Waldman, N, 2014)
" All six studies demonstrated that a short course of dilute topical anesthetic provided efficacious analgesia without adverse effects or delayed epithelial healing."2.52The Safety of Topical Anesthetics in the Treatment of Corneal Abrasions: A Review. ( Milne, K; Otterness, K; Rezaie, S; Swaminathan, A, 2015)
"Postoperative pain was significantly elevated in patients who used tetracaine on POD 1 and POD 7."1.56Assessment of Factors Associated With Postoperative Pain After Photorefractive Keratectomy. ( Apsey, DA; Caldwell, MC; Evangelista, C; Gillis, J; Justin, GA; Legault, GL; Palochak, CMA; Santamaria, J; Steigleman, WA, 2020)
"Tetracaine was dispensed at the initial visit for 303 SCA presentations (57%) and inappropriately for 141 NSCA presentations (14%)."1.48An Observational Study to Determine Whether Routinely Sending Patients Home With a 24-Hour Supply of Topical Tetracaine From the Emergency Department for Simple Corneal Abrasion Pain Is Potentially Safe. ( Densie, I; Giddings, G; Gray, A; McMaster, S; Meanley, J; Waldman, N; Winrow, B, 2018)

Research

Studies (16)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's13 (81.25)24.3611
2020's3 (18.75)2.80

Authors

AuthorsStudies
Palochak, CMA1
Santamaria, J1
Justin, GA1
Apsey, DA1
Caldwell, MC1
Steigleman, WA1
Evangelista, C1
Legault, GL1
Gillis, J1
Jehle, D1
Lark, MC1
O'Brien, C1
Shipman, S1
Painter, K1
Keuchel, M1
Bogie, C1
Waldman, N4
Winrow, B1
Densie, I1
Gray, A1
McMaster, S1
Giddings, G1
Meanley, J1
Crabb, MG1
Liu, E1
Freeman, A1
Hsu, T1
Supramaniam, D1
Kaidonis, G1
Glading, J1
Keane, MC1
Cugati, S1
Lake, SR1
Saha, N1
Landers, J1
Craig, JE1
Densie, IK3
Herbison, P2
Ufberg, JW1
Karras, DJ1
Pruet, CM1
Feldman, RM1
Kim, G1
Tijunelis, M1
Tozer, K1
Swaminathan, A1
Otterness, K1
Milne, K1
Rezaie, S1
Blaha, GR1
Tilton, EP1
Barouch, FC1
Marx, JL1
Castellanos, MA1
Schwartz, S1
Leal, R1
Chan, RV1
Quiroz-Mercado, H1
Shah, NV1
Vaddavalli, PK1
Chow, JH1
Roman, JS1
Shi, W1
Yoo, SH1
Sanabria, MR1
Montero, JA1
Losada, MV1
Fernández-Muñoz, M1
Galindo, A1
Fernández, I1
Coco, RM1
Sampedro, A1

Clinical Trials (5)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Short Term Topical Tetracaine is Safe and Highly Efficacious for the Treatment of Pain Caused by Corneal Abrasions: a Double-blind Randomized Clinical Trial[NCT04187417]118 participants (Actual)Interventional2015-01-01Completed
Treatment of Corneal Abrasions With Topical Tetracaine: an Evaluation of Safety and Efficacy[NCT02771392]Phase 2/Phase 3120 participants (Anticipated)Interventional2016-06-30Not yet recruiting
A Prospective, Randomised, Single-masked Comparison of Topical Anesthesia and Topical Combined Subconjunctival (Two-step) Anesthesia in Intravitreal Injection[NCT03871062]60 participants (Anticipated)Interventional2019-03-08Recruiting
Comparison of Three Different Anesthetic Approaches for Intravitreal Injections: A Prospective Randomized Trial[NCT02263690]Phase 492 participants (Actual)Interventional2014-06-30Completed
Comparison of 0.5% Tetracaine Drops Versus 2% Lidocaine Gel for Anesthetic Efficacy and Comfort in Patients Undergoing LASIK[NCT01383200]Phase 411 participants (Actual)Interventional2011-06-30Terminated (stopped due to eyes that received gel had slightly thinner than intended flaps)
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Participants Score on Pain Scale

Do you have sharp pain in your eye? Pain will be assessed by units on a scale of 1-5: 1 means no symptoms, 2 means slight discomfort, 3 means mild discomfort, 4 means moderate discomfort, and 5 means severe discomfort (NCT01383200)
Timeframe: 1 hour (60minutes) post LASIK operation

InterventionScore on scale (Mean)
Tetracaine1.95
Lidocaine2.01

Reviews

1 review available for tetracaine and Eye Pain

ArticleYear
The Safety of Topical Anesthetics in the Treatment of Corneal Abrasions: A Review.
    The Journal of emergency medicine, 2015, Volume: 49, Issue:5

    Topics: Anesthetics, Local; Corneal Injuries; Eye Pain; Humans; Propoxycaine; Tetracaine; Wound Healing

2015

Trials

6 trials available for tetracaine and Eye Pain

ArticleYear
Short-Term Topical Tetracaine Is Highly Efficacious for the Treatment of Pain Caused by Corneal Abrasions: A Double-Blind, Randomized Clinical Trial.
    Annals of emergency medicine, 2021, Volume: 77, Issue:3

    Topics: Administration, Topical; Adolescent; Adult; Aged; Aged, 80 and over; Analgesics; Corneal Injuries; D

2021
The intravitreal injection pain study: a randomized control study comparing subjective pain with injection technique.
    Acta ophthalmologica, 2019, Volume: 97, Issue:8

    Topics: Administration, Ophthalmic; Adult; Anesthetics, Local; Angiogenesis Inhibitors; Eye Pain; Humans; In

2019
Topical tetracaine used for 24 hours is safe and rated highly effective by patients for the treatment of pain caused by corneal abrasions: a double-blind, randomized clinical trial.
    Academic emergency medicine : official journal of the Society for Academic Emergency Medicine, 2014, Volume: 21, Issue:4

    Topics: Administration, Ophthalmic; Adolescent; Adult; Aged; Anesthetics, Local; Cornea; Corneal Injuries; D

2014
Topical tetracaine used for 24 hours is safe and rated highly effective by patients for the treatment of pain caused by corneal abrasions: a double-blind, randomized clinical trial.
    Academic emergency medicine : official journal of the Society for Academic Emergency Medicine, 2014, Volume: 21, Issue:4

    Topics: Administration, Ophthalmic; Adolescent; Adult; Aged; Anesthetics, Local; Cornea; Corneal Injuries; D

2014
Topical tetracaine used for 24 hours is safe and rated highly effective by patients for the treatment of pain caused by corneal abrasions: a double-blind, randomized clinical trial.
    Academic emergency medicine : official journal of the Society for Academic Emergency Medicine, 2014, Volume: 21, Issue:4

    Topics: Administration, Ophthalmic; Adolescent; Adult; Aged; Anesthetics, Local; Cornea; Corneal Injuries; D

2014
Topical tetracaine used for 24 hours is safe and rated highly effective by patients for the treatment of pain caused by corneal abrasions: a double-blind, randomized clinical trial.
    Academic emergency medicine : official journal of the Society for Academic Emergency Medicine, 2014, Volume: 21, Issue:4

    Topics: Administration, Ophthalmic; Adolescent; Adult; Aged; Anesthetics, Local; Cornea; Corneal Injuries; D

2014
Randomized trial of anesthetic methods for intravitreal injections.
    Retina (Philadelphia, Pa.), 2011, Volume: 31, Issue:3

    Topics: Aged; Aged, 80 and over; Anesthesia, Local; Anesthetics, Local; Angiogenesis Inhibitors; Antibodies,

2011
Randomized trial of anesthetic methods for intravitreal injections.
    Retina (Philadelphia, Pa.), 2011, Volume: 31, Issue:3

    Topics: Aged; Aged, 80 and over; Anesthesia, Local; Anesthetics, Local; Angiogenesis Inhibitors; Antibodies,

2011
Randomized trial of anesthetic methods for intravitreal injections.
    Retina (Philadelphia, Pa.), 2011, Volume: 31, Issue:3

    Topics: Aged; Aged, 80 and over; Anesthesia, Local; Anesthetics, Local; Angiogenesis Inhibitors; Antibodies,

2011
Randomized trial of anesthetic methods for intravitreal injections.
    Retina (Philadelphia, Pa.), 2011, Volume: 31, Issue:3

    Topics: Aged; Aged, 80 and over; Anesthesia, Local; Anesthetics, Local; Angiogenesis Inhibitors; Antibodies,

2011
Prospective, double-masked, randomized trial comparing lidocaine gel to tetracaine drops in femtosecond laser-assisted LASIK.
    Journal of refractive surgery (Thorofare, N.J. : 1995), 2012, Volume: 28, Issue:10

    Topics: Anesthetics, Local; Corneal Stroma; Double-Blind Method; Eye Pain; Gels; Humans; Intraoperative Comp

2012
Ocular pain after intravitreal injection.
    Current eye research, 2013, Volume: 38, Issue:2

    Topics: Aged; Aged, 80 and over; Anesthetics, Local; Angiogenesis Inhibitors; Anti-Bacterial Agents; Anti-In

2013

Other Studies

9 other studies available for tetracaine and Eye Pain

ArticleYear
Assessment of Factors Associated With Postoperative Pain After Photorefractive Keratectomy.
    Cornea, 2020, Volume: 39, Issue:10

    Topics: Administration, Ophthalmic; Adult; Anesthetics, Local; Eye Pain; Female; Humans; Lasers, Excimer; Ma

2020
Failure of painful eye movements to respond to topical anesthetics supports the diagnosis of optic neuritis.
    The American journal of emergency medicine, 2021, Volume: 42

    Topics: Adult; Anesthetics, Local; Eye Movements; Eye Pain; Female; Humans; Magnetic Resonance Imaging; Midd

2021
An Observational Study to Determine Whether Routinely Sending Patients Home With a 24-Hour Supply of Topical Tetracaine From the Emergency Department for Simple Corneal Abrasion Pain Is Potentially Safe.
    Annals of emergency medicine, 2018, Volume: 71, Issue:6

    Topics: Adolescent; Adult; Anesthetics, Local; Corneal Injuries; Drug Administration Schedule; Emergency Ser

2018
Dogma challenged: tetracaine for corneal abrasions?
    Academic emergency medicine : official journal of the Society for Academic Emergency Medicine, 2014, Volume: 21, Issue:4

    Topics: Anesthetics, Local; Corneal Injuries; Eye Injuries; Eye Pain; Female; Humans; Male; Tetracaine

2014
Re: "topical tetracaine used for 24 hours is safe and rated highly effective by patients for the treatment of pain caused by corneal abrasions: a double-blind, randomized clinical trial".
    Academic emergency medicine : official journal of the Society for Academic Emergency Medicine, 2014, Volume: 21, Issue:9

    Topics: Anesthetics, Local; Corneal Injuries; Eye Injuries; Eye Pain; Female; Humans; Male; Tetracaine

2014
In reply.
    Academic emergency medicine : official journal of the Society for Academic Emergency Medicine, 2014, Volume: 21, Issue:9

    Topics: Anesthetics, Local; Corneal Injuries; Eye Injuries; Eye Pain; Female; Humans; Male; Tetracaine

2014
Good study design, but flawed conclusion in emergency department tetracaine use.
    Academic emergency medicine : official journal of the Society for Academic Emergency Medicine, 2014, Volume: 21, Issue:11

    Topics: Anesthetics, Local; Corneal Injuries; Eye Injuries; Eye Pain; Female; Humans; Male; Tetracaine

2014
Good study design, but flawed conclusion in emergency department tetracaine use. In reply.
    Academic emergency medicine : official journal of the Society for Academic Emergency Medicine, 2014, Volume: 21, Issue:11

    Topics: Anesthetics, Local; Corneal Injuries; Eye Injuries; Eye Pain; Female; Humans; Male; Tetracaine

2014
Pain assessment in premature infants treated with intravitreal antiangiogenic therapy for retinopathy of prematurity under topical anesthesia.
    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2013, Volume: 251, Issue:2

    Topics: Anesthesia, Local; Anesthetics, Local; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; B

2013